Latest News about REGN
Recent news which mentions REGN
Here's Why I Bought This Recent Genetics IPO
September 22, 2021
From Motley Fool
Where to Invest $100 Right Now
September 22, 2021
From Motley Fool
NNVC Stock: What Is Going on With Red-Hot NanoViricides Today?
September 21, 2021
From InvestorPlace
3 COVID Stocks to Buy in a Bear Market
September 21, 2021
From Motley Fool
Sanofi, Regeneron, Share Competitive Libtayo Survival Data in 1L NSCLC
September 20, 2021
From Benzinga
AbbVie's Pain Is Sanofi's and Regeneron's Gain
September 18, 2021
From Motley Fool
Smart Investors Are Watching This Trend Right Now
September 16, 2021
From Motley Fool
7 Gene Editing Stocks Promising to Change our DNA
September 15, 2021
From InvestorPlace
Alaska joins Idaho in rationing health care as hospitals are packed with COVID patients, and WHO says Africa is being left behind in vaccine push
September 15, 2021
From MarketWatch
Breaking Down The Inflation Numbers Draws Attention To Oil Prices
September 15, 2021
From Benzinga
10 Biggest Price Target Changes For Wednesday
September 15, 2021
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
From Benzinga
These Promising Clinical Results Could Be Huge for Amgen Investors
September 11, 2021
From Motley Fool
Can Pfizer Beat Sanofi and Regeneron in the Eczema Market?
September 11, 2021
From Motley Fool
3 Stocks to Watch in September
September 10, 2021
From Motley Fool
Could This Label Expansion Be a Blockbuster for AbbVie's Shareholders?
September 09, 2021
From Motley Fool
3 Hot Stocks to Buy in September
September 07, 2021
From Motley Fool
3 Biotech Stocks That Soared to New Heights Last Week
September 05, 2021
From Motley Fool
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
From Benzinga
3 Biotech Stocks That Are Too Cheap to Ignore
September 02, 2021
From Motley Fool
Now May Be the Big Moment for These 2 COVID Stocks
September 02, 2021
From Motley Fool
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
Could CRISPR Therapeutics Stock Help You Retire a Millionaire?
August 31, 2021
From Motley Fool
From Benzinga
Can COVID-19 Antibody Treatment Help In High-Risk Cases? Mayo Clinic, nference Study Shows Potential
August 30, 2021
From Benzinga
Pfizer's Abrocitinib Beats Dupixent Late-stage Eczema Trial
August 30, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
